Related Experiment Video

Updated: Apr 1, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.5K

Inflammatory markers in primary aldosteronism

Z Šomlóová1, O Petrák, J Rosa

  • 1Third Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. zuzana.kratka@vfn.cz.

Physiological Research
|October 9, 2015
PubMed

Insights

Primary aldosteronism (PA) shows no difference in inflammatory markers compared to essential hypertension (EH). However, patients with PA exhibit elevated N-terminal propeptide of collagen I (PINP) levels, indicating potential differences in vascular health.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Primary aldosteronism (PA) is a leading cause of endocrine hypertension, frequently associated with cardiovascular complications.
  • Aldosterone may contribute to adverse cardiometabolic profiles through inflammation and collagen synthesis.
  • Understanding these mechanisms is crucial for managing PA patients.

Purpose of the Study:

  • To compare levels of inflammatory markers (hsCRP, IL-6, TNF-alpha) and collagen synthesis marker (PINP) in PA versus essential hypertension (EH).
  • To investigate differences in these markers between PA subtypes: aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism (IHA).

Main Methods:

  • A case-control study involving 28 PA patients (including APA and IHA subtypes) and 28 matched EH patients.
  • Measurement of serum hsCRP, IL-6, TNF-alpha, leukocytes, and PINP levels.
  • Statistical analysis to compare marker levels between groups.

Main Results:

  • No significant differences were found in hsCRP, IL-6, TNF-alpha, or leukocyte levels between PA and EH groups.
  • No significant differences in inflammatory markers were observed between APA and IHA subtypes.
  • Significantly higher levels of N-terminal propeptide of collagen I (PINP) were detected in PA patients compared to EH patients (p ≤ 0.003).

Conclusions:

  • Inflammatory markers do not appear to differentiate PA from EH.
  • Elevated PINP levels in PA suggest increased collagen synthesis and potential vascular remodeling.
  • Further research is needed to elucidate the role of collagen synthesis in PA-related cardiovascular complications.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.6K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

6.0K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
754
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.1K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.9K